Provided by Tiger Trade Technology Pte. Ltd.

Xylem

101.44
-0.3800-0.37%
Volume:804.09K
Turnover:81.43M
Market Cap:23.68B
PE:24.14
High:102.10
Open:101.86
Low:100.70
Close:101.82
52wk High:154.27
52wk Low:98.58
Shares:233.49M
Float Shares:231.60M
Volume Ratio:0.51
T/O Rate:0.35%
Dividend:1.66
Dividend Rate:1.64%
EPS(TTM):4.20
EPS(LYR):3.92
ROE:9.18%
ROA:5.11%
PB:2.27
PE(LYR):25.88

Loading ...

Xylem Q2 Adjusted Earnings, Revenue Increase; 2026 Adjusted EPS Guidance Lifted

MT Newswires Live
·
Jul 28

GUIDANCE: (XYL) Xylem Expects Full Year 2026 Adjusted EPS Range $5.55 - $5.70,, vs. FactSet Est of $5.55

MT Newswires Live
·
Jul 28

Xylem raises FY26 adjusted EPS view to $5.55-$5.70 from $5.35-$5.60

TIPRANKS
·
Jul 28

Xylem Q2 FY26 EPS Rises 19% to $1.11; Revenue Increases 2% to $2.34 Billion

Reuters
·
Jul 28

Xylem Q2 Adj. EPS $1.46 Beats $1.34 Estimate, Sales $2.336B Miss $2.341B Estimate

Benzinga Earnings
·
Jul 28

Xylem Outlook FY Adjusted Ebitda Margin 23.1-23.5%

THOMSON REUTERS
·
Jul 28

Xylem Q2 Revenue USD 2,300 Million VS. Ibes Estimate USD 2,341 Million

THOMSON REUTERS
·
Jul 28

Is Xylem (XYL) Undervalued As Its Simplification Drive Points To Higher Margins?

Simply Wall St.
·
Jul 26

Xylem Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 25

JPMorgan Downgrades Xylem to Neutral From Overweight, Cuts Price Target to $130 From $140

MT Newswires Live
·
Jul 21

Xylem downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Jul 21

Earning Preview: Xylem Q2 revenue is expected to increase by 5.84%, and institutional views are bullish

Earnings Agent
·
Jul 21

Xylem Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 21

Xylem is Maintained at Buy by Stifel

Dow Jones
·
Jul 20

Jefferies Adjusts Price Target on Xylem to $145 From $140, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Unusually active option classes on open July 17th

TIPRANKS
·
Jul 17

Xylem Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 17

Xylem is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 16

RBC Capital Adjusts Price Target on Xylem to $159 From $157, Maintains Outperform Rating

MT Newswires Live
·
Jul 16

How Investors Can Swing for the Fences with $100,000 Now

Dow Jones
·
Jul 16